Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice

Clicks: 136
ID: 271166
2012
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT) anticoagulation is required. Heparin is still the most commonly used anticoagulant. However, heparins increase the risk of bleeding, especially in critically ill patients. Evidence has accumulated th ā€¦
Reference Key
hm2012criticalbench-to-bedside Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oudemans-van Straaten HM;Ostermann M;;
Journal critical care (london, england)
Year 2012
DOI DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/23216871
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine anticoagulants / adverse effects anticoagulants / therapeutic use* pmid:23216871 pmc3672558 doi:10.1186/cc11645 heleen m oudemans-van straaten marlies ostermann blood coagulation / drug effects citric acid / adverse effects citric acid / therapeutic use* renal replacement therapy / methods*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.